LoginSignup
image de profil
Laura
@LaurasInvest
2Année·

How do you currently estimate $NVAX (-0,4 %) and $VLA (-2,4 %) rate?


I am currently down about 76% on Novavax and about 71% on Valneva.


From $BAVA (+0,22 %) this week with a little plus. Now I have the question, wait for a turnaround in the other two or rather sell now to avoid going even further into the red?


I know, no one has a crystal ball but the exchange is always interesting. ☺️

1
9 Commentaires
image de profil
Jonas 🕊️@TheAccountant89
2Année
What was your exit strategy when buying? It may be that you now get 20 different opinions and thus ultimately do not become smarter. Therefore, always ask the following questions at the beginning of the purchase: -What is the fair value of the company? -How long do I want to hold the stock and in which scenario do I have to sell it? -What is the business model and does the company have a competitive advantage over the competition? Understand the company and become aware of the opportunities and risks. My guess is that you haven't asked yourself at least two of these questions. Ultimately, only you can answer your questions.
•
4
•
Utilisateur supprimé
2Année
Le commentaire a été supprimé
image de profil
Jonas 🕊️@TheAccountant89
2Année
@BarstenJr This is less an art than simple rules of investing. What do you do at -10%, what at -20%, etc.? Is the investment thesis still valid or not? If you have studied the company intensively, you can certainly answer these questions. You can only find strong companies if you look at them yourself. And that's where it starts again... what do you mean by "strong companies"? This results from your own analysis and not because a few people say so or because the company is well-known or has many well-known products. That's simply not enough.

The problem is that you only ask such questions if you are too unsure of yourself due to a lack of analysis. I know that sounds a bit harsh and you can certainly learn from these mistakes (which I did, of course). And I don't mean that everyone has to be an expert in balance sheet analysis. You should just be sure of yourself and question yourself regularly.
••
Utilisateur supprimé
2Année
Le commentaire a été supprimé
image de profil
Jonas 🕊️@TheAccountant89
2Année
@BarstenJr I understand your point of view. But you should also take a close look at the well-known companies. This can also backfire there. In that case, I would rather recommend an ETF.

Because even with these companies you have an investment thesis. I am a long-term investor, but if this no longer applies, you have to sell. And the -20% is actually always a good time to think about it or buy more if necessary. As I said... once you have answered certain questions for yourself, you know what to do, regardless of which stock you buy.
••
image de profil
Dom@SSVDom
2Année
I also have Valneva in my portfolio, I'm also down around 70%, but I'm holding for the long term. Work together with Pfizer on a Lyme disease vaccine, it is expected to be approved in 2025. I am convinced for the long term and will also lower my buy in again and buy more.
•
3
•
Kai Wirt@Aktien2022
2Année
I would still keep Novavax and possibly wait that the vlt bring out new vaccines, which can increase sales. I am also in the red with them...🥴
••
image de profil
Leuchtturm@Leuchtturm
2Année
@Aktien2022 what does the company's information say about the development of new vaccines, so long the company is not to be seen as "growth potential"
••
image de profil
Leuchtturm@Leuchtturm
2Année
@Aktien2022 because research is one thing - clinical trials and market approvals are another 🤔.
••
Participez à la conversation
S'inscrireConnexion